 |
Holle LM. 2005
Outpatient prospective payment system final rules: summary of oncology
medications. Oncology Reimbursement Connection.
A Newsletter for Oncology Pharmacists, Nurses, Social Workers, and
Office Managers. 2005;2(4):1-7.
Butler SB. 2005 Medicare physician
fee schedule final rule: summary of oncology-related provisions.
Oncology Reimbursement Connection. A Newsletter
for Oncology Pharmacists, Nurses, Social Workers, and Office Managers.
2005;2(4):7-9.
Jung LL. Rationale for deletionof
ICD-9CM information from compendia update. Oncology
Reimbursement Connection. A Newsletter for Oncology Pharmacists,
Nurses, Social Workers, and Office Managers.
2005;2(4):11,13.
Jung LL. Outpatient prospective payment system
proposed rule. Oncology Reimbursement
Connection. A Newsletter for Oncology Pharmacists, Nurses, Social
Workers, and Office Managers. 2004;2(3):1-6.
Walsh TL, Morris AK, Holle LM,
et al. Granisetron versus ondansetron for prevention of nausea and
vomiting in hematopoietic stem cell transplant patients: results
of a prospective, double-blind, randomized trial. Bone Marrow
Transplant. 2004;34(11):963-968.
Jung L, Holle L, Dalton
WS. Discovery, development, and clinical applications of bortezomib.
Oncology (Huntington). 2004;18(14 suppl 11):4-13.
Schwartz R, Davidson T.
Pharmacology, pharmacokinetics, and practical applications of bortezomib.
Oncology (Huntington). 2004;18(14 suppl 11):14-21.
Jung LL, Ramanathan
RK, Egorin MJ, et al. Pharmacokinetic studies of 9-nitrocamptothecin
(9NC) on intermittent and continuous schedules of administration
in patients with solid tumors. Cancer Chemother Pharmacol.
2004;54(6):487-496.
Zamboni WC, Jung LL,
Egorin MG, et al. Phase I and pharmacologic study of intermittently
administered 9-nitrocamptothecin in patients with advanced solid
tumors. Clin Cancer Res. 2004;10:5058-5064.
Day S, Jung LL, McPeek
JJ. Prevention of medical-claim denials and the appeal process.
Oncology Reimbursement Connection. A Newsletter for Oncology
Pharmacists, Nurses, Social Workers, and Office Managers. 2004;2(2):3-8.
Allen C, Day S. Compendia
update. Oncology Reimbursement Connection. A Newsletter for
Oncology Pharmacists, Nurses, Social Workers, and Office Managers.
2004;2(2):11.
Butler S. 2004 Outpatient
Prospective Payment System Reform. Oncology Reimbursement Connection.
A Newsletter for Oncology Pharmacists, Nurses, Social Workers, and
Office Managers. 2004;2(1):1-5.
Allen C, Day S.
Disbursement of Medicare dollars: the role of fiscal intermediaries,
carriers, and local coverage determinations. Oncology Reimbursement
Connection. A Newsletter for Oncology Pharmacists, Nurses, Social
Workers, and Office Managers. 2004;2(1):5-6.
Day SD. Darbepoetin
alfa (Aranesp®): practical issues in the management
of chemotherapy-related anemia. Oncology Reimbursement Connection.
A Newsletter for Oncology Pharmacists, Nurses, Social Workers, and
Office Managers. 2003;1(3):1-4.
Holle LM. Understanding
the outpatient prospective payment system. Oncology Reimbursement
Connection. A Newsletter for Oncology Pharmacists, Nurses, Social
Workers, and Office Managers. 2003;1(2):1-6.
Day SD. Expanding the
applications of imatinib mesylate (Gleevec™) in the treatment of
chronic myelogenous leukemia. Oncology Reimbursement Connection.
A Newsletter for Oncology Pharmacists, Nurses, Social Workers, and
Office Managers. 2003;1(1):1-3.
Walsh TL, Valley AW, Holle LM,
et al. Granisetron versus ondansetron in the prevention of nausea
and vomiting in bone marrow transplant patients: results of a prospective,
double-blind, randomized trial. Presented at: 2002 American Society
for Blood and Marrow Transplantation Tandem Meetings; February 2002;
Keystone, Colo. Abstract 175.
Jung LL, Schwartz RN.
Darbepoetin alfa: a review of its use in patients with cancer. Cancer
Practice. 2002;10(6):327-330.
Jung LL, Zamboni WC,
Schwartz RN. Hypercalcemia. In: Schwinghammer T, Yee G, eds. Pharmacotherapy:
A Patient-Focused Approach. 5th ed. New York, NY: McGraw-Hill;
2002:156-159.
Zamboni WC, Jung LL,
Tonda M. Ovarian cancer. In: Dipiro J, Talbert R, Matzke G, Posey
L, eds. Pharmacotherapy: A Pathophysiological Approach.
5th ed. New York, NY: McGraw Hill; 2002:2357-2372.
Zamboni WC, Jung LL,
Tonda M. Ovarian cancer. In: Schwinghammer T, Yee G, eds. Pharmacotherapy:
A Patient-Focused Approach. 5th ed. New York, NY: McGraw-Hill;
2002:367-371.
Jung LL, Zamboni WC.
Cellular pharmacokinetic and pharmacodynamic aspects of response
to camptothecins: perspectives to future response. Drug Resistance
Updates. 2001;4(4):273-288.
|
|
